Cargando…

Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion

BACKGROUND: The presence or future development of metastatic pheochromocytomas or paragangliomas (mPPGLs) can be difficult to diagnose or predict at initial presentation. Since production of catecholamines from mPPGLs is different from non-metastatic tumors (non-mPPGLs), this study aimed to clarify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Minghao, Pamporaki, Christina, Fliedner, Stephanie M. J., Timmers, Henri J. L. M., Nölting, Svenja, Beuschlein, Felix, Prejbisz, Aleksander, Remde, Hanna, Robledo, Mercedes, Bornstein, Stefan R., Lenders, Jacques W. M., Eisenhofer, Graeme, Bechmann, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777503/ https://www.ncbi.nlm.nih.gov/pubmed/35201450 http://dx.doi.org/10.1007/s12672-021-00404-x

Ejemplares similares

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma
por: Rao, Dipti, et al.
Publicado: (2017)

Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging
por: Rogowski-Lehmann, Natalie, et al.
Publicado: (2018)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses
por: Fischer, Alessa, et al.
Publicado: (2023)

Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma
por: Eisenhofer, Graeme, et al.
Publicado: (2022)

Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine
por: Richter, Susan, et al.
Publicado: (2022)

Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology
por: Constantinescu, Georgiana, et al.
Publicado: (2022)

THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023)

Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma
por: Bliziotis, Nikolaos G., et al.
Publicado: (2021)

Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches
por: Gieldon, Laura, et al.
Publicado: (2019)

Update on Modern Management of Pheochromocytoma and Paraganglioma
por: Lenders, Jacques W. M., et al.
Publicado: (2017)

Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma
por: Berends, Annika M.A., et al.
Publicado: (2019)

Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension
por: Constantinescu, Georgiana, et al.
Publicado: (2020)

Targeting Cyclooxygenase-2 in Pheochromocytoma and Paraganglioma: Focus on Genetic Background
por: Ullrich, Martin, et al.
Publicado: (2019)

Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model
por: Helm, Jana, et al.
Publicado: (2022)

Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
por: Richter, Susan, et al.
Publicado: (2018)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision Medicine
por: Nölting, Svenja, et al.
Publicado: (2019)

Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review
por: Li, Minghao, et al.
Publicado: (2021)

Correction to: Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review
por: Li, Minghao, et al.
Publicado: (2021)

Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells
por: Bechmann, Nicole, et al.
Publicado: (2019)

Anti-Cancer Potential of MAPK Pathway Inhibition in Paragangliomas–Effect of Different Statins on Mouse Pheochromocytoma Cells
por: Fliedner, Stephanie M. J., et al.
Publicado: (2014)

The Clinical Characteristics of Pheochromocytomas and Paragangliomas with Negative Catecholamines
por: Zhao, Lin, et al.
Publicado: (2022)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma
por: Maison, Nicole, et al.
Publicado: (2016)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
por: Calsina, Bruna, et al.
Publicado: (2023)

Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
por: Monteagudo, María, et al.
Publicado: (2021)

Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
por: Mellid, Sara, et al.
Publicado: (2023)

Catecholamine Metabolism in Paraganglioma and Pheochromocytoma: Similar Tumors in Different Sites?
por: Grouzmann, Eric, et al.
Publicado: (2015)

Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma
por: Wang, Yi, et al.
Publicado: (2022)

Correlation between catecholamines and echocardiographic parameters in patients with pheochromocytoma and paraganglioma
por: Wang, Chunyan, et al.
Publicado: (2022)

Evaluation of Head and Neck Paragangliomas by Computed Tomography in Patients with Pheochromocytoma-Paraganglioma Syndromes
por: Michałowska, Ilona, et al.
Publicado: (2016)

Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
por: Cascón, Alberto, et al.
Publicado: (2019)

Response to Letter to the Editor from Berends et al: “Approach to the Patient: Perioperative Management of the Patient With Pheochromocytoma or Sympathetic Paraganglioma”
por: Berends, Annika M A, et al.
Publicado: (2020)

Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Extensive patient-to-patient single nucleus transcriptome heterogeneity in pheochromocytomas and paragangliomas
por: Brazda, Peter, et al.
Publicado: (2022)

Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome
por: Ziegler, Christian G., et al.
Publicado: (2022)

PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization
por: Fischer, Alessa, et al.
Publicado: (2023)

Anti-Tumorigenic and Anti-Metastatic Activity of the Sponge-Derived Marine Drugs Aeroplysinin-1 and Isofistularin-3 against Pheochromocytoma In Vitro
por: Bechmann, Nicole, et al.
Publicado: (2018)

The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy
por: Eisenhofer, Graeme, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3prk0rf44qed1h73mq8qqq55io